[1] |
Huang Yaxin, He Yuanmin, Huang Shuli, Xiong Xia, Deng Yongqiong.
An investigation into clinical significance of serum chitinase 3-like protein 1 in pemphigus vulgaris
[J]. Chinese Journal of Dermatology, 2022, 55(6): 523-527.
|
[2] |
Wang Yanyan, Wang Xiaoju, Wang Yuhuan, Gu Tianming, Ding Jiashuo.
Identification of core contents of health education for patients with pemphigus by using the Delphi method
[J]. Chinese Journal of Dermatology, 2022, 55(6): 516-518.
|
[3] |
Shan Ying, Zuo Yagang.
Correlation between autoimmune bullous diseases and psoriasis
[J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455.
|
[4] |
Hu Feng, Wang Xiangdong, Xia Yun, Zhou Xiaoyong, Chen Liuqing.
Pemphigus foliaceus converting into bullous pemphigoid: the first case reported in China
[J]. Chinese Journal of Dermatology, 2022, 55(2): 156-158.
|
[5] |
Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming.
Pathogenesis and targeted therapy of pemphigus
[J]. Chinese Journal of Dermatology, 2022, 0(1): 20210248-e20210248.
|
[6] |
Liu Zhong, Hu Jisheng, Huang Meng, Chen Liuqing, Qin Li, Zhou Xiaoyong.
Efficacy of low-dose rituximab combined with glucocorticoids in a case of childhood pemphigus foliaceus: a clinical observation
[J]. Chinese Journal of Dermatology, 2021, 54(5): 436-437.
|
[7] |
Li Lili, Sun Xiukun, Shen Hong.
Analysis of skin microbiota diversity in patients with pemphigus based on 16S rDNA sequences
[J]. Chinese Journal of Dermatology, 2021, 54(3): 212-219.
|
[8] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Azathioprine in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2021, 54(2): 116-121.
|
[9] |
Shan Ying, Chang Xiaotong, Zuo Yagang.
Epitope spreading in autoimmune bullous diseases
[J]. Chinese Journal of Dermatology, 2021, 0(1): 20201019-e20201019.
|
[10] |
Li Zhiliang, Zhang Hanmei, Xiang Ruiyu, Jing Ke, Feng Suying.
Correlation of anti?desmoglein conformational epitope antibody and anti?acetylcholine receptor antibody titers with disease activity of pemphigus vulgaris
[J]. Chinese Journal of Dermatology, 2020, 53(6): 435-438.
|
[11] |
Tang Jia, Shi Ying, Zhou Junfeng, Chen Yao, Li Shanshan.
Two cases of familial benign pemphigus treated with botulinum toxin type A
[J]. Chinese Journal of Dermatology, 2020, 53(5): 368-370.
|
[12] |
Chang Yuan, Chen Xixue, Wang Mingyue, Zhang Chenyang, Zhu Xuejun.
Long-term effectiveness and safety of rituximab for the treatment of pemphigus
[J]. Chinese Journal of Dermatology, 2020, 53(4): 279-284.
|
[13] |
Sun Zufeng, Chen Jingjing, Zhu Hong, Zhou Min, Wen Zhihua, Gu Ningyan, Zhang Yu, Yao Xu.
Analysis of risk factors for osteoporosis in patients with pemphigus treated with systemic glucocorticoids
[J]. Chinese Journal of Dermatology, 2020, 53(4): 296-298.
|
[14] |
Zou Yaru, Pan Meng, Yuan Huijie, Zhou Shengru, Zhao Xiaoqing, Zheng Jie, Zhu Haiqin.
Local infiltration of tissue-resident memory CD4+ T cells in lesions of patients with pemphigus and its clinical implications
[J]. Chinese Journal of Dermatology, 2020, 53(12): 974-978.
|
[15] |
Committee on Autoimmune Diseases, China Dermatologist Association.
Mycophenolate mofetil in the treatment of immune?related skin diseases: an expert proposal
[J]. Chinese Journal of Dermatology, 2020, 53(11): 869-874.
|